Explore how proteomics in drug discovery supports drug target identification, biomarker discovery and the unearthing of safer ...

Learn how accelerating drug discovery is reshaping the pathway from lab findings to effective therapies with real-world data.

A drug for pulmonary fibrosis created using artificial intelligence (AI) is showing early promise in patients.

At Medicilon, we’re proud to be at the forefront of this transformation. Our NAMs Drug R&D Service Platform integrates ...

AI has advanced molecule design, yet synthetic feasibility remains a bottleneck. Chemistry-first approaches offer a practical ...

A researcher has proposed a more targeted approach to AI drug discovery, which includes a rigorous evaluation protocol.

EDINBURGH and CAMBRIDGE, United Kingdom, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC™ platform in ...

Genomics unveils Mystra at ASHG 2025—an AI genetics platform to accelerate drug discovery and clinical validation using large-scale genetic data.

Three posters to be presented featuring pre-clinical data of potential best-in-class FGFR3 selective inhibitor, SMARCA2 selective inhibitor, and ...

Charles River Laboratories International, Inc. (NYSE:CRL) today announced a strategic collaboration with X-Chem, Inc., the pioneer in DNA-encoded library (DEL) technology and a data-driven drug ...